In 2025, the United States is facing a new twist in the vaccine hesitancy conversation. While debates over safety and efficacy have always existed, a unique phenomenon has emerged: some Americans are opting for Ivermectin USA as a perceived alternative to mRNA vaccines. This shift—driven by misinformation, economic concerns, and regional trust gaps—has caught the...